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ABSTRACT
Transcription activator-like effector nucleases
(TALENs) are powerful new research tools that
enable targeted gene disruption in a wide variety
of model organisms. Recent work has shown that
TALENs can induce mutations in endogenous
zebrafish genes, but to date only four genes have
been altered, and larger-scale tests of the success
rate, mutation efficiencies and germline transmis-
sion rates have not been described. Here, we
constructed homodimeric TALENs to 10 different
targets in various endogenous zebrafish genes and
found that 7 nuclease pairs induced targeted indel
mutations with high efficiencies ranging from
2 to 76%. We also tested obligate heterodimeric
TALENs and found that these nucleases induce
mutations with comparable or higher frequencies
and have better toxicity profiles than their
homodimeric counterparts. Importantly, mutations
induced by both homodimeric and heterodimeric
TALENs are passed efficiently through the
germline, in some cases reaching 100% transmis-
sion. For one target gene sequence, we observed
substantially reduced mutagenesis efficiency for a
variant site bearing two mismatched nucleotides,
raising the possibility that TALENs might be used
to perform allele-specific gene disruption. Our
results suggest that construction of one to two
heterodimeric TALEN pairs for any given gene will,
in most cases, enable researchers to rapidly
generate knockout zebrafish.
INTRODUCTION
Customized endonucleases have become indispensable
tools for genome editing in human somatic and pluripo-
tent stem cells, rats, Drosophila, Caenorhabditis elegans,
plants and zebraﬁsh (1–5). These enzymes are engineered
to create site-speciﬁc double-strand deoxyribonucleic
acid (DNA) breaks (DSBs) that can be repaired by
non-homologous end joining, resulting in insertions and
deletions (indels) that disrupt the reading frame and
function of the targeted gene (6–13). Alternatively, DSBs
can also be repaired via homologous recombination (HR),
thereby incorporating speciﬁc sequence modiﬁcations
provided on a donor template (14–17).
One class of endonucleases that has drawn much
interest is the transcription activator-like effector nucle-
ases (TALENs) (18–23). These enzymes consist of a
fusion between the non-speciﬁc cleavage domain from
the naturally occurring Type IIS FokI endonuclease and
a transcription activator-like (TAL) effector DNA recog-
nition domain. The TAL effector recognition domain
comprises an N-terminal domain that recognizes a 50 T
in the binding site, a variable number of highly conserved
33–35 amino acid repeats each capable of specifying a
single DNA nucleotide, and C-terminal sequence from
naturally occurring TAL effector proteins. The identities
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variable di-residues or RVDs) are associated with different
DNA-binding speciﬁcities. Repeats bearing different
RVDs have been identiﬁed that recognize each of the
four DNA nucleotides, and these domains can be
assembled into arrays capable of binding virtually any
DNA sequence that begins with a 50 T (18). The simplicity
of design, robust activity and nearly limitless targeting
range of the TALENs make this platform very attractive
for genome editing.
Previously, we and another group showed that
TALENs could effectively induce targeted disruption of
four different endogenous genes in zebraﬁsh but germline
transmission was only demonstrated for two of these
genes (19,20). In this study, we sought to perform tests
with a larger number of genes to determine the success
rate for obtaining active TALENs capable of robustly
cleaving zebraﬁsh genes, to assess the efﬁciency of
transmitting TALEN-induced mutations through the
germline and to compare the activities of TALENs that
harbor homodimeric or obligate heterodimeric FokI
cleavage domains. We addressed these questions by
examining the activities of homodimeric and hetero-
dimeric TALEN pairs designed for target sites present in
six different zebraﬁsh genes. Our results demonstrate that
most TALENs are highly active in zebraﬁsh, that
TALEN-induced mutations can be efﬁciently transmitted
through the zebraﬁsh germline and that heterodimeric
TALENs show similar or greater activities than their
homodimeric counterparts. Our ﬁndings provide strong
support for the idea that TALENs will enable facile
generation of zebraﬁsh knockout lines for nearly all
endogenous zebraﬁsh genes.
MATERIALS AND METHODS
Zebraﬁsh care
All zebraﬁsh care and uses were approved by the
Massachusetts General Hospital Subcommittee on
Research Animal Care.
Construction of TALEN expression vectors
Homodimeric TALENs harboring a wild-type FokI
nuclease domain were assembled using the fast ligation-
based automatable solid-phase high-throughput (FLASH)
method as described previously (18). Heterodimeric
TALENs were generated by digesting sequence-veriﬁed
homodimeric TALEN clones with NheI and BamHI and
cloning them into expression vectors MLM290/292 that
contain EL and KK heterodimeric FokI domains (avail-
able through the nonproﬁt plasmid repository, Addgene),
or equivalent vectors that contain additional N496D or
H537R mutations (yielding ELD and KKR heterodimeric
FokI domains) described by Doyon et al. (24). The nu-
cleotide sequences of the ELD and KKR nuclease expres-
sion vectors can be found in Supplementary Figure S1.
The nucleotide sequences of the TALE repeat arrays and
the full amino acid sequences of the TALENs used in this
study can be found in Supplementary Figures S2 and S3.
Production of TALEN mRNAs
TALEN expression vectors were linearized with PmeI,
which were then used for in vitro transcription using the
mMESSAGE mMACHINE T7 ULTRA kit (Ambion).
The transcribed RNAs were polyadenylated using the
reagents in the same kit.
Microinjection and analysis of somatic mutations
Approximately 2 nl of the TALEN messenger ribonucleic
acid (mRNAs, 300pg/nl) was injected into one-cell stage
zebraﬁsh embryos. On the next day, the surviving injected
embryos were grouped into either ‘normal’ or ‘deformed’
phenotypes. Genomic DNA was extracted from pools of
12 embryos from each ‘normal’ group as previously
described (25). Targeted genomic loci were ampliﬁed
using primers designed to anneal approximately 150–200
base pairs upstream and downstream from the expected
cut site. A list of the primers used in this study is provided
in Supplementary Figure S4. The resulting polymerase
chain reaction (PCR) product was cloned into
pGEM-5Zf(+) using the pGEM-T Easy kit (Promega).
After transformation of the ligated vectors, single
colonies were reinoculated for plasmid DNA isolation
and sequencing. The sequence of each clone represents
one ampliﬁed allele. In this study, we sequenced approxi-
mately 48–96 clones for each target site and determined
somatic mutation rates based on the percentages of the
mutated alleles. According to statistical analysis, we will
have a greater than 95% probability of detecting at least
one mutant allele by screening 48 clones for a TALEN
pair that has a mutation efﬁciency of 6.25% or higher.
Similarly, we will have greater than 95% conﬁdence for
detecting at least one mutant allele by screening 96 clones
for a TALEN pair that has mutation efﬁciency of 3.125%
or higher. Therefore, given the number of clones we
sequenced in our experiments, we may not be able to
reliably detect indel mutations for TALEN pairs that
have targeting efﬁciencies below 3–6%.
Founder screen
Potential founders were crossed with wild-type zebraﬁsh.
Three to four days post-fertilization, progeny were lysed
individually in 25ml of the alkaline lysis buffer (25mM
NaOH, 0.2mM ethylenediaminetetraacetic acid) and
heated at 95 C for 30min. Subsequently, the DNA
solution was neutralized using 25ml of the neutralization
buffer (40mM Tris-HCl). Samples were spun at 3000rpm
for 5min, and the supernatant contained extracted
genomic DNA. In general, 12 embryos from each poten-
tial founder were screened for the presence of
TALEN-induced mutations by PCR amplifying the
region surrounding the relevant TALEN cleavage site
using a 6-FAM-labeled ﬂuorescent forward primer and a
regular reverse primer (Supplementary Figure S4). The
ﬂuorescent PCR products were analyzed on ABI 3730xl
DNA analyzer to evaluate their sizes (25). For sequence
conﬁrmation, genomic DNAs from single embryos
were ampliﬁed using targeted loci-speciﬁc primers, and
the PCR products were cloned into pGEM-5Zf(+)
8002 Nucleic Acids Research, 2012,Vol.40, No. 16vector as described above. The resulting clones were
sequenced and the mutations were determined.
RESULTS
Activities of obligate heterodimeric TALENs in zebraﬁsh
In previous work, we showed that TALENs harboring
wild-type homodimeric FokI nuclease domains could efﬁ-
ciently induce targeted mutations in zebraﬁsh, whereas
Huang et al. successfully targeted two zebraﬁsh genes
using TALENs harboring modiﬁed heterodimeric FokI
nuclease domains (19,20). We wished to compare the
activities of homodimeric TALENs to corresponding
heterodimeric TALENs. Obligate heterodimeric nuclease
domains should reduce unwanted homodimeric pairing
between two identical TALEN molecules, thereby
increasing the formation of the desired heterodimer and
reducing potential ‘off-target’ effects caused by homo-
dimers. Heterodimeric FokI domains used in engineered
ZFNs have shown reduced off-target cleavage events in
human cells as well as reduced cytotoxicity (24,26–28).
However, obligate heterodimeric ZFNs have also been
reported to possess less activity than their homodimeric
counterparts, and therefore, we were interested in
investigating the activities of TALENs made with
heterodimeric FokI domains (24,26).
For an initial experiment, we chose two pairs of
heterodimeric FokI domains referred to as EL/KK and
ELD/KKR that have been previously described and
used for engineering heterodimeric ZFNs (24,26). [Note
that these FokI domains differ from the ones used by
Huang et al. (20).] Speciﬁcally, we made heterodimeric
versions of a homodimeric TALEN pair, which we had
previously shown sounded redundant can induce somatic
indel mutations in 33% of gria3a gene alleles in zebraﬁsh
embryos (19). We found that both heterodimeric gria3a
TALEN pairs induced smaller numbers of deformed
embryos ( 20% of deformed and dead embryos for
both EL/KK and ELD/KKR versus  40% of those for
the homodimeric pair) and were also moderately more
active in their abilities to induce somatic gene mutations
in the gria3a gene (42% for EL/KK and 61% for ELD/
KKR) than the homodimeric pair from which they were
derived (Figure 1 and Supplementary Figure S5). These
results suggest that TALENs constructed with either EL/
KK or ELD/KKR heterodimeric FokI domains are not
only well tolerated in zebraﬁsh embryos but also induce
high rates of target site cleavage. Because the ELD/KKR
heterodimers were more active than the EL/KK
heterodimers in both our TALEN experiment and previ-
ously published studies performed with ZFNs in human
cells (24), we chose to utilize ELD/KKR TALENs for
our subsequent experiments.
Success rates and mutagenic efﬁciencies of homodimeric
and heterodimeric TALENs
To better deﬁne the success rates and the effectiveness of
the TALEN platform for mutating endogenous zebraﬁsh
genes, we performed a larger-scale test of homodimeric
and heterodimeric TALENs. On the basis of the results
of a recent systematic and large-scale test of various length
TALENs we recently performed in human cells (18), we
chose to construct TALENs composed of 16.5 TALE
repeats in all of our studies.
We initially designed and constructed homodimeric
TALENs for 10 target sites found in the ﬁrst 3 exons of
6 endogenous zebraﬁsh genes (Supplementary Figure S6).
Among these genes, we had previously targeted hif1ab and
slc6a3 (also known as dopamine transporter, dat) with
customized ZFNs but at sites toward the end of their
coding regions (10). We found that 7 of these 10
TALEN pairs efﬁciently induced indels at their targeted
loci in the TALEN mRNA-injected embryos with somatic
mutation rates ranging from 2 to 76% (Figure 2a and
Supplementary Figure S7). In addition, for all six genes
we sought to mutate, we successfully identiﬁed at least one
pair of TALENs that cleave efﬁciently within the ﬁrst
three exons (the reliable detection limit of our assay is
(a) (b)
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Figure 1. Targeting efﬁciencies and toxicities of homodimeric and heterodimeric TALENs in zebraﬁsh. (a) Percentages of dead, deformed and
normal (OK) embryos at 1day after injection with TALEN-coding mRNAs. The total number of embryos scored (n) is 165, 110 and 127 for WT,
EL/KK and ELD/KKR, respectively. (b) Mutation rates in somatic zebraﬁsh cells are determined as described in ‘Materials and Methods’ section
and are shown here. Mutated sequences can be found in Supplementary Figure S5. The TALENs constructed in two heterodimeric frameworks
showed increased targeting efﬁciencies and reduced toxicities compared to their homodimeric counterparts.
Nucleic Acids Research, 2012,Vol.40, No. 16 8003approximately 3–6% as discussed in the ‘Materials and
Methods’ section). Our large-scale test suggests that
TALENs have a high success rate in zebraﬁsh and
that active nucleases can robustly mutagenize their
targeted loci.
To investigate the activities of heterodimeric TALENs,
we constructed ELD/KKR versions of 8 of the 10
homodimeric TALEN pairs described above and then
tested their abilities to induce somatic mutations in
zebraﬁsh. In general, heterodimeric TALENs showed
comparable or higher activities (from 0.8- to 7-fold)
than their homodimeric counterparts (Figure 2a and
Supplementary Figure S7). Interestingly, TALENs that
failed to show activities as homodimers were also
inactive as heterodimers. Taken together, these results
suggest that, in contrast to the results of others in
human cells (24), the ELD/KKR heterodimeric
TALENs have equivalent or higher activities than homo-
dimeric TALENs in zebraﬁsh.
Given the reported improved speciﬁcity of hetero-
dimeric nucleases relative to homodimeric nucleases
(24,28), we compared the toxicities of matched
homodimeric and heterodimeric TALENs. To do this,
we compared the percentages of normal embryos one
day after microinjection of mRNAs encoding
homodimeric and heterodimeric TALENs. Our results
show that homodimeric TALENs exhibit variable levels
of toxicities (16–73% of normal embryos), while hetero-
dimeric TALENs are more consistently well tolerated
(32–75% of normal embryos) (Figure 2b). Therefore,
these results suggest that the ELD/KKR heterodimeric
TALENs may provide a less toxic alternative to
homodimeric TALENs for mutagenizing zebraﬁsh.
Preferential allelic disruption of a zebraﬁsh gene using
TALENs
While performing sequence analysis of a clutch of
epas1b.2-targeted embryos, we unexpectedly identiﬁed a
two base pair polymorphism (AA!GC) in one allele
that falls within the left target half-site of the TALENs
targeted to that gene. In the embryos injected with
homodimeric TALENs targeted to the epas1b.2 site, we
found that the allele with the correct target sequence
was mutated with a frequency of 76%, whereas the allele
with the target sequence harboring the two mismatches
were mutated with a frequency of only 2% (Figure 3).
Similarly, heterodimeric TALENs targeted to the
epas1b.2 site-induced mutations in 58% of the alleles
with the correct target sequences but in only 3% of the
alleles bearing the 2-bp mismatch (Figure 3). These data
indicate that both homodimeric and heterodimeric
TALENs can exhibit strong selectivity toward their
intended target sequences, with the ability to discriminate
(a)
(b)
Figure 2. Engineered TALENs are highly efﬁcient in targeting endogenous zebraﬁsh genes. (a) Frequencies of mutations induced by homodimeric
and heterodimeric TALENs targeting 10 endogenous loci in zebraﬁsh. The number of clones depicts the total number of alleles including wild-type
and mutant alleles that have been sequenced. The ratios of mutation rates between heterodimeric and homodimeric TALENs are also shown.
(b) Comparison of the toxicity induced by homodimeric and heterodimeric TALENs. The percentages of normal embryos at 1day after injection
with TALEN-coding mRNAs are shown. A total of 30–189 embryos were scored for each TALEN pair. The number of embryos scored for each
TALEN pair is shown in Supplementary Figure S8.
8004 Nucleic Acids Research, 2012,Vol.40, No. 16between alleles and sites that differ by as few as two
nucleotides.
High-transmission rates of heritable mutations induced
by TALENs
The published literature to date describes only two
examples for which TALEN-induced mutations have
been transmitted through the germline in zebraﬁsh (20).
By using two TALEN pairs described in our previous
report (for gria 3a and hey2) (19) and six pairs from this
study (for elmo1, epas1b, fh, hif1ab, ptpmt1 and slc6a3),
we performed founder screens for a total of eight different
zebraﬁsh genes. We successfully identiﬁed founders for all
of these eight genes and found that both homodimeric
and heterodimeric TALENs induce heritable mutations
that can be transmitted through the germline (Figure 4).
For the epas1b, fh and gria3a gene targets, we found
that all the potential ﬁsh we screened (from two to eight
ﬁsh for each gene target) could transmit heritable
mutations with percentages of mutant embryos from
each founder ranging from 25 to 75% (Figure 4).
Of note, the somatic mutation rates for those three
TALEN pairs were 76% for epas1b, 60% for fh and
33% for gria3a (Figures 1b and 2a). For hey2, hif1ab,
ptpmt1 and slc6a3 [the somatic mutation rates for these
TALEN pairs ranged from 11 to 65%, Figure 2a (19)],
we were able to identify one or more founders for each
of these gene targets by screening 4–12 potential founder
ﬁsh (12 embryos from each ﬁsh). Even for the elmo1
TALEN pair that induced a somatic mutation rate of
only 8% (Figure 2a), we identiﬁed one founder after
screening 22 ﬁsh (12 embryos from each ﬁsh) (Figure 4).
As has been observed previously with ZFNs, for several
TALEN pairs, we observed more than one type of herit-
able mutation from a single founder, suggesting that those
mutations occurred independently in different germ cells
within the same animal (Figures 4 and 5). Overall,
our results demonstrate that TALENs are highly efﬁcient
and sufﬁciently non-toxic to zebraﬁsh embryonic cells so
Figure 3. Frequencies and sequences of somatic mutations induced by TALENs at their intended or variant target loci. Both homodimeric and
heterodimeric TALENs targeting epas1b.2 induced high rates of indel mutations at their intended target loci. However, their targeting efﬁciencies at
a variant target locus with a 2 base pair mismatch were reduced signiﬁcantly. The TALEN constructs used and their mutation rates are as indicated
(SQT418/419, homodimeric TALEN constructs; WH7/8, ELD/KKR heterodimeric TALEN constructs). The wild-type sequence is shown at the top
with TALEN binding sites marked in yellow. Deletions are indicated by gray highlighted red dashes and insertions by blue highlighted lower case
letters. The sizes of the indels are labeled to the right of each sequence (+, insertion;  , deletion). The number of times each mutant allele was
isolated is shown in brackets.
Nucleic Acids Research, 2012,Vol.40, No. 16 8005Figure 4. TALENs induce high rates of heritable mutations. Fish that had been previously injected with either homodimeric or heterodimeric
TALENs were screened for founders carrying heritable mutations. The targeted gene and the TALEN pairs injected are indicated at the top of each
panel. Individual embryos from each potential founder were lysed for PCR analysis. Indel mutations were identiﬁed by the presence of the PCR size
variants. Except for hey2 and gria3a, the sequences of the mutant alleles have been determined by sequencing (Figure 5). TALEN 1295/1260,
1297/1257 and the SQT constructs encode homodimeric TALEN pairs, whereas the WH constructs encode ELD/KKR heterodimeric TALENs.
aThe
number of embryos that possessed indel mutations are shown outside of the parentheses, and the sizes of the indels are shown inside the parentheses.
Some of the mutation sequences are shown in Figure 5.
8006 Nucleic Acids Research, 2012,Vol.40, No. 16as to enable efﬁcient transmission of mutations through
the germline.
DISCUSSION
TALENs have been shown previously to be capable of
generating mutations in endogenous zebraﬁsh genes
(19,20), but success rates, somatic mutation rates,
toxicities and germline transmission efﬁciencies
determined from large-scale studies have not yet been
reported. In addition, the most recent generation of
obligate heterodimeric FokI nuclease domains have not
yet been used with TALENs in zebraﬁsh (24). In this
study, we sought to use the FLASH method recently
described by our group to perform a large-scale assess-
ment of the TALEN platform for mutating zebraﬁsh
genes (18).
Our results show that both homodimeric and
heterodimeric TALENs can efﬁciently modify their
targeted loci in zebraﬁsh. Seven of the 10 homodimeric
TALEN pairs constructed induced mutations with
efﬁciencies as high as 76%. For eight of the 10
homodimeric TALEN pairs, we constructed obligate
heterodimeric versions using the ELD/KKR FokI
nuclease domains. We found that these heterodimeric
TALEN pairs exhibited either comparable or, in most
Figure 5. Sequences of heritable mutations induced by TALENs. For six of the eight genes that are shown in Figure 4, we have determined the
sequences of all the mutant alleles identiﬁed in the progeny of the founders by sequencing. Potential founders were generated by injection of either
homodimeric (SQT constructs) or heterodimeric (WH constructs) TALEN mRNAs as indicated. The MT numbers shown at the left of the sequences
represent the founder numbers, which correspond to the founder numbers shown in Figure 4. Sometimes different mutant alleles were found in
different embryos from a single founder. For the sequences, the wild-type sequence is shown at the top with TALEN binding sites marked in yellow.
Deletions are indicated by gray highlighted red dashes and insertions by blue highlighted lower case letters. The sizes of the indels are labeled to the
right of each sequence (+, insertion;  , deletion).
Nucleic Acids Research, 2012,Vol.40, No. 16 8007cases, increased somatic mutation activities (ranging from
a two- to seven-fold increase). This ﬁnding was somewhat
surprising because it differs from what has been observed
with the activities of heterodimeric ELD/KKR ZFNs in
human cells where these nucleases show somewhat lower
activities than their homodimeric counterparts (24). The
heterodimeric TALENs also appear to exhibit less cyto-
toxicity than their matched homodimeric counterparts as
judged by the percentage of normal embryos observed
after injection of TALEN-encoded mRNAs. This ﬁnding
is consistent with the observation that heterodimeric
ZFNs possess improved speciﬁcities relative to matched
homodimeric ZFNs (24, 28). Our results show that
TALENs assembled on the FLASH platform have a
high success rate (as measured by their abilities to
induce mutations in somatic zebraﬁsh cells) and that
active nucleases can efﬁciently mutagenize their intended
targets, a ﬁnding consistent with our recent demonstration
that FLASH-assembled TALENs have a >88% success
rate for targeting endogenous genes in human cells and
that active nucleases induce mutations with high
efﬁciencies (18). In addition, our ﬁndings suggest that
heterodimeric ELD/KKR TALENs may be more active
and less toxic than their homodimeric counterparts. Taken
together, we conclude that heterodimeric ELD/KKR
TALENs are preferable to homodimeric TALENs for
use in zebraﬁsh.
Our data provide a larger scale demonstration that
TALEN-induced mutations can be successfully trans-
mitted through the germline. Previous reports with
TALENs in zebraﬁsh have shown germline transmission
for only two zebraﬁsh genes (20). In this report, we show
that TALEN-induced mutations in eight different en-
dogenous gene targets can be transmitted through the
germline using either homodimeric or heterodimeric
TALENs. In some cases, we found that all the ﬁsh we
screened were founders. Our results suggest that
founders can typically be identiﬁed after screening as
few as 5–10 ﬁsh injected with TALEN mRNAs if the
somatic mutation rate of the TALENs is above 10%.
Nevertheless, transmissible mutations may still occur
even if the somatic mutation rate falls below 10%, as in
the case of elmo1 and as has been shown in a previous
report (20). In this study, more than 70% of the effective
homodimeric or heterodimeric TALEN pairs we tested
resulted in a somatic mutation rate above 10%.
Interestingly, we found that one of our TALEN pairs
exhibits a high degree of speciﬁcity for its intended target
site. This pair showed greatly reduced activity at a
polymorphic target allele that contains two mismatches
from the intended sequence. Targeting efﬁciency for this
polymorphic sequence was decreased signiﬁcantly for both
homodimeric and heterodimeric TALENs. This result
indicates that TALENs can exhibit strong speciﬁcity for
their intended binding sequence even when an alternative
target bears as few as two differences. This ﬁnding
parallels that observed for a TALEN pair targeted to
the human CCR5 gene, which showed selectivity against
an off-target site that differed by only two mismatches
from the intended site (29). Our result also strongly
suggests the exciting possibility that it may be possible
to design allele-speciﬁc TALENs that can selectively
mutagenize one allele when two different alleles are
present in a single cell. Additional experiments will be
needed to test whether this ﬁnding can be generalized to
other target sites.
The results of our study demonstrate that the TALEN
technology is a simple, robust and efﬁcient platform for
performing targeted gene disruption in zebraﬁsh. Our
ﬁndings lead to some practical suggestions for investiga-
tors interested in using this technology: (i) Most genes
can be successfully targeted by generating TALENs for
just one or two sites, (ii) heterodimeric ELD/KKR
TALENs are superior to homodimeric TALENs due to
their higher activities and lower toxicities and (iii)
founders can be identiﬁed by screening as few as a
handful of ﬁsh. The results of this report, together with
another recent study showing that TALENs have an es-
sentially limitless targeting range and can be rapidly
assembled in high-throughput using the FLASH
assembly method (18), strongly suggest that it may now
be feasible to rapidly create very large collections of
mutant zebraﬁsh. We also note that all TALENs used
in this and our previous study (19) are built on a par-
ticular architecture that has been shown to yield
nucleases that can efﬁciently modify genes in C. elegans
(22), rats (30) and human somatic (18, 23) and pluripo-
tent stem cells (21). A number of other architectures for
building TALENs have been described (20, 29, 31–42),
and it will be of interest to see whether TALENs built on
these other platforms also show similarly high success
rates and efﬁciencies in zebraﬁsh.
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Supplementary Data are available at NAR Online:
Supplementary Figures 1–8.
ACKNOWLEDGEMENTS
The authors thank Cherie Ramirez for providing the
expression vectors containing ELD/KKR FokI nuclease
domains and for helpful discussions.
FUNDING
National Institutes of Health (NIH) [R01 GM088040 to
J.K.J. and R.T.P.]; NIH Director’s Pioneer Award [DP1
OD006862 to J.K.J., T32 CA009216 to J.D.S. and K01
AG031300 to J.-R.J.Y.]; Jim and Ann Orr MGH
Research Scholar award (to J.K.J.); Charles and Ann
Sanders MGH Research Scholar award (to R.T.P.);
National Science Foundation [DBI-0923827 to D.R.].
Funding for open access charge: NIH.
Conﬂict of interest statement. JKJ has a ﬁnancial interest
in Transposagen Biopharmaceuticals. JKJ’s interests were
reviewed and are managed by Massachusetts General
Hospital and Partners HealthCare in accordance with
their conﬂict of interest policies.
8008 Nucleic Acids Research, 2012,Vol.40, No. 16REFERENCES
1. Porteus,M.H. and Carroll,D. (2005) Gene targeting using zinc
ﬁnger nucleases. Nat. Biotechnol., 23, 967–973.
2. Cathomen,T. and Joung,J.K. (2008) Zinc-ﬁnger nucleases: the
next generation emerges. Mol. Ther., 16, 1200–1207.
3. Kandavelou,K. and Chandrasegaran,S. (2009) Custom-designed
molecular scissors for site-speciﬁc manipulation of the plant and
mammalian genomes. Methods Mol. Biol., 544, 617–636.
4. Sander,J.D., Yeh,J.R., Peterson,R.T. and Joung,J.K. (2011)
Engineering zinc ﬁnger nucleases for targeted mutagenesis of
zebraﬁsh. Methods Cell Biol., 104, 51–58.
5. Carroll,D., Beumer,K.J., Morton,J.J., Bozas,A. and
Trautman,J.K. (2008) Gene targeting in Drosophila and
Caenorhabditis elegans with zinc-ﬁnger nucleases. Methods Mol.
Biol., 435, 63–77.
6. Bibikova,M., Golic,M., Golic,K.G. and Carroll,D. (2002)
Targeted chromosomal cleavage and mutagenesis in Drosophila
using zinc-ﬁnger nucleases. Genetics, 161, 1169–1175.
7. Santiago,Y., Chan,E., Liu,P.Q., Orlando,S., Zhang,L.,
Urnov,F.D., Holmes,M.C., Guschin,D., Waite,A., Miller,J.C.
et al. (2008) Targeted gene knockout in mammalian cells by using
engineered zinc-ﬁnger nucleases. Proc. Natl Acad. Sci. USA, 105,
5809–5814.
8. Perez,E.E., Wang,J., Miller,J.C., Jouvenot,Y., Kim,K.A., Liu,O.,
Wang,N., Lee,G., Bartsevich,V.V., Lee,Y.L. et al. (2008)
Establishment of HIV-1 resistance in CD4+ T cells by genome
editing using zinc-ﬁnger nucleases. Nat. Biotechnol., 26, 808–816.
9. Doyon,Y., McCammon,J.M., Miller,J.C., Faraji,F., Ngo,C.,
Katibah,G.E., Amora,R., Hocking,T.D., Zhang,L., Rebar,E.J.
et al. (2008) Heritable targeted gene disruption in zebraﬁsh using
designed zinc-ﬁnger nucleases. Nat. Biotechnol., 26, 702–708.
10. Foley,J.E., Yeh,J.R., Maeder,M.L., Reyon,D., Sander,J.D.,
Peterson,R.T. and Joung,J.K. (2009) Rapid mutation of
endogenous zebraﬁsh genes using zinc ﬁnger nucleases made by
Oligomerized Pool ENgineering (OPEN). PLoS One, 4, e4348.
11. Meng,X., Noyes,M.B., Zhu,L.J., Lawson,N.D. and Wolfe,S.A.
(2008) Targeted gene inactivation in zebraﬁsh using engineered
zinc-ﬁnger nucleases. Nat. Biotechnol., 26, 695–701.
12. Sander,J.D., Dahlborg,E.J., Goodwin,M.J., Cade,L., Zhang,F.,
Cifuentes,D., Curtin,S.J., Blackburn,J.S., Thibodeau-Beganny,S.,
Qi,Y. et al. (2011) Selection-free zinc-ﬁnger-nuclease engineering
by context-dependent assembly (CoDA). Nat. Methods, 8, 67–69.
13. Geurts,A.M., Cost,G.J., Freyvert,Y., Zeitler,B., Miller,J.C.,
Choi,V.M., Jenkins,S.S., Wood,A., Cui,X., Meng,X. et al. (2009)
Knockout rats via embryo microinjection of zinc-ﬁnger nucleases.
Science, 325, 433.
14. Urnov,F.D., Miller,J.C., Lee,Y.L., Beausejour,C.M., Rock,J.M.,
Augustus,S., Jamieson,A.C., Porteus,M.H., Gregory,P.D. and
Holmes,M.C. (2005) Highly efﬁcient endogenous human gene
correction using designed zinc-ﬁnger nucleases. Nature, 435,
646–651.
15. Beumer,K., Bhattacharyya,G., Bibikova,M., Trautman,J.K. and
Carroll,D. (2006) Efﬁcient gene targeting in Drosophila with
zinc-ﬁnger nucleases. Genetics, 172, 2391–2403.
16. Cui,X., Ji,D., Fisher,D.A., Wu,Y., Briner,D.M. and
Weinstein,E.J. (2011) Targeted integration in rat and
mouse embryos with zinc-ﬁnger nucleases. Nat. Biotechnol., 29,
64–67.
17. Zou,J., Maeder,M.L., Mali,P., Pruett-Miller,S.M.,
Thibodeau-Beganny,S., Chou,B.K., Chen,G., Ye,Z., Park,I.H.,
Daley,G.Q. et al. (2009) Gene targeting of a disease-related gene
in human induced pluripotent stem and embryonic stem cells.
Cell Stem Cell, 5, 97–110.
18. Reyon,D., Tsai,S.Q., Khayter,C., Foden,J.A., Sander,J.D. and
Joung,J.K. (2012) FLASH assembly of TALENs for
high-throughput genome editing. Nat. Biotechnol., 30, 460–465.
19. Sander,J.D., Cade,L., Khayter,C., Reyon,D., Peterson,R.T.,
Joung,J.K. and Yeh,J.R. (2011) Targeted gene disruption in
somatic zebraﬁsh cells using engineered TALENs. Nat.
Biotechnol., 29, 697–698.
20. Huang,P., Xiao,A., Zhou,M., Zhu,Z., Lin,S. and Zhang,B. (2011)
Heritable gene targeting in zebraﬁsh using customized TALENs.
Nat. Biotechnol., 29, 699–700.
21. Hockemeyer,D., Wang,H., Kiani,S., Lai,C.S., Gao,Q.,
Cassady,J.P., Cost,G.J., Zhang,L., Santiago,Y., Miller,J.C. et al.
(2011) Genetic engineering of human pluripotent cells using
TALE nucleases. Nat. Biotechnol., 29, 731–734.
22. Wood,A.J., Lo,T.W., Zeitler,B., Pickle,C.S., Ralston,E.J.,
Lee,A.H., Amora,R., Miller,J.C., Leung,E., Meng,X. et al. (2011)
Targeted genome editing across species using ZFNs and
TALENs. Science, 333, 307.
23. Miller,J.C., Tan,S., Qiao,G., Barlow,K.A., Wang,J., Xia,D.F.,
Meng,X., Paschon,D.E., Leung,E., Hinkley,S.J. et al. (2011)
A TALE nuclease architecture for efﬁcient genome editing.
Nat. Biotechnol., 29, 143–148.
24. Doyon,Y., Vo,T.D., Mendel,M.C., Greenberg,S.G., Wang,J.,
Xia,D.F., Miller,J.C., Urnov,F.D., Gregory,P.D. and Holmes,M.C.
(2011) Enhancing zinc-ﬁnger-nuclease activity with improved
obligate heterodimeric architectures. Nat. Methods, 8, 74–79.
25. Foley,J.E., Maeder,M.L., Pearlberg,J., Joung,J.K., Peterson,R.T.
and Yeh,J.R. (2009) Targeted mutagenesis in zebraﬁsh using
customized zinc-ﬁnger nucleases. Nat. Protoc., 4, 1855–1867.
26. Miller,J.C., Holmes,M.C., Wang,J., Guschin,D.Y., Lee,Y.L.,
Rupniewski,I., Beausejour,C.M., Waite,A.J., Wang,N.S.,
Kim,K.A. et al. (2007) An improved zinc-ﬁnger nuclease
architecture for highly speciﬁc genome editing. Nat. Biotechnol.,
25, 778–785.
27. Szczepek,M., Brondani,V., Buchel,J., Serrano,L., Segal,D.J. and
Cathomen,T. (2007) Structure-based redesign of the dimerization
interface reduces the toxicity of zinc-ﬁnger nucleases. Nat.
Biotechnol., 25, 786–793.
28. Gabriel,R., Lombardo,A., Arens,A., Miller,J.C., Genovese,P.,
Kaeppel,C., Nowrouzi,A., Bartholomae,C.C., Wang,J.,
Friedman,G. et al. (2011) An unbiased genome-wide analysis of
zinc-ﬁnger nuclease speciﬁcity. Nat. Biotechnol., 29, 816–823.
29. Mussolino,C., Morbitzer,R., Lutge,F., Dannemann,N., Lahaye,T.
and Cathomen,T. (2011) A novel TALE nuclease scaffold enables
high genome editing activity in combination with low toxicity.
Nucleic Acids Res., 39, 9283–9293.
30. Tesson,L., Usal,C., Menoret,S., Leung,E., Niles,B.J., Remy,S.,
Santiago,Y., Vincent,A.I., Meng,X., Zhang,L. et al. (2011)
Knockout rats generated by embryo microinjection of TALENs.
Nat. Biotechnol., 29, 695–696.
31. Cermak,T., Doyle,E.L., Christian,M., Wang,L., Zhang,Y.,
Schmidt,C., Baller,J.A., Somia,N.V., Bogdanove,A.J. and
Voytas,D.F. (2011) Efﬁcient design and assembly of custom
TALEN and other TAL effector-based constructs for DNA
targeting. Nucleic Acids Res., 39, e82.
32. Christian,M., Cermak,T., Doyle,E.L., Schmidt,C., Zhang,F.,
Hummel,A., Bogdanove,A.J. and Voytas,D.F. (2010) Targeting
DNA double-strand breaks with TAL effector nucleases. Genetics,
186, 757–761.
33. Geissler,R., Scholze,H., Hahn,S., Streubel,J., Bonas,U.,
Behrens,S.E. and Boch,J. (2011) Transcriptional activators of
human genes with programmable DNA-speciﬁcity. PLoS One, 6,
e19509.
34. Li,L., Piatek,M.J., Atef,A., Piatek,A., Wibowo,A., Fang,X.,
Sabir,J.S., Zhu,J.K. and Mahfouz,M.M. (2012) Rapid and highly
efﬁcient construction of TALE-based transcriptional regulators and
nucleases for genome modiﬁcation. Plant Mol. Biol., 78, 407–416.
35. Li,T., Huang,S., Jiang,W.Z., Wright,D., Spalding,M.H.,
Weeks,D.P. and Yang,B. (2011) TAL nucleases (TALNs): hybrid
proteins composed of TAL effectors and FokI DNA-cleavage
domain. Nucleic Acids Res., 39, 359–372.
36. Li,T., Huang,S., Zhao,X., Wright,D.A., Carpenter,S.,
Spalding,M.H., Weeks,D.P. and Yang,B. (2011) Modularly
assembled designer TAL effector nucleases for targeted gene
knockout and gene replacement in eukaryotes. Nucleic Acids Res.,
39, 6315–6325.
37. Mahfouz,M.M., Li,L., Shamimuzzaman,M., Wibowo,A., Fang,X.
and Zhu,J.K. (2011) De novo-engineered transcription
activator-like effector (TALE) hybrid nuclease with novel DNA
binding speciﬁcity creates double-strand breaks. Proc. Natl Acad.
Sci. USA, 108, 2623–2628.
38. Morbitzer,R., Elsaesser,J., Hausner,J. and Lahaye,T. (2011)
Assembly of custom TALE-type DNA binding domains by
modular cloning. Nucleic Acids Res., 39, 5790–5799.
Nucleic Acids Research, 2012,Vol.40, No. 16 800939. Morbitzer,R., Romer,P., Boch,J. and Lahaye,T. (2010) Regulation
of selected genome loci using de novo-engineered transcription
activator-like effector (TALE)-type transcription factors. Proc.
Natl Acad. Sci. USA, 107, 21617–21622.
40. Sanjana,N.E., Cong,L., Zhou,Y., Cunniff,M.M., Feng,G. and
Zhang,F. (2012) A transcription activator-like effector toolbox for
genome engineering. Nat. Protoc., 7, 171–192.
41. Weber,E., Gruetzner,R., Werner,S., Engler,C. and Marillonnet,S.
(2011) Assembly of designer TAL effectors by Golden Gate
cloning. PLoS One, 6, e19722.
42. Zhang,F., Cong,L., Lodato,S., Kosuri,S., Church,G.M. and
Arlotta,P. (2011) Efﬁcient construction of sequence-speciﬁc TAL
effectors for modulating mammalian transcription. Nat.
Biotechnol., 29, 149–153.
8010 Nucleic Acids Research, 2012,Vol.40, No. 16